Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Short term Debt (2016 - 2025)

Historic Short term Debt for Harvard Bioscience (HBIO) over the last 13 years, with Q3 2025 value amounting to $34.0 million.

  • Harvard Bioscience's Short term Debt rose 84195.78% to $34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.0 million, marking a year-over-year increase of 84195.78%. This contributed to the annual value of $37.0 million for FY2024, which is 53075.61% up from last year.
  • Per Harvard Bioscience's latest filing, its Short term Debt stood at $34.0 million for Q3 2025, which was up 84195.78% from $34.9 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Short term Debt registered a high of $37.0 million during Q4 2024, and its lowest value of $2.0 million during Q1 2021.
  • Moreover, its 5-year median value for Short term Debt was $3.5 million (2023), whereas its average is $10.0 million.
  • In the last 5 years, Harvard Bioscience's Short term Debt tumbled by 2981.83% in 2021 and then surged by 86661.29% in 2025.
  • Harvard Bioscience's Short term Debt (Quarter) stood at $3.2 million in 2021, then rose by 17.81% to $3.8 million in 2022, then skyrocketed by 53.74% to $5.9 million in 2023, then skyrocketed by 530.76% to $37.0 million in 2024, then fell by 8.09% to $34.0 million in 2025.
  • Its Short term Debt was $34.0 million in Q3 2025, compared to $34.9 million in Q2 2025 and $36.0 million in Q1 2025.